209 related articles for article (PubMed ID: 20553479)
1. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Shandal V; Kumar R
BJU Int; 2010 Jul; 106(1):132-3. PubMed ID: 20553479
[No Abstract] [Full Text] [Related]
2. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
3. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Majhail NS; Urbain JL; Albani JM; Kanvinde MH; Rice TW; Novick AC; Mekhail TM; Olencki TE; Elson P; Bukowski RM
J Clin Oncol; 2003 Nov; 21(21):3995-4000. PubMed ID: 14581422
[TBL] [Abstract][Full Text] [Related]
4. Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
Thambugala GM; Mohamed A; O' Neill GF; Fulham MJ
Australas Radiol; 2006 Dec; 50(6):604-6. PubMed ID: 17107535
[TBL] [Abstract][Full Text] [Related]
5. Renal Cell Carcinoma Arising From Renal Allograft Detected by 18F-FDG PET-CT.
Guo Y; Wang T
Clin Nucl Med; 2016 May; 41(5):412-3. PubMed ID: 26825198
[TBL] [Abstract][Full Text] [Related]
6. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
Bouchelouche K; Choyke PL
PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
[TBL] [Abstract][Full Text] [Related]
7. Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Steffens MG; Mulders PF; Brouwers AH; Oyen WJ
J Urol; 2002 Nov; 168(5):2127-8. PubMed ID: 12394731
[No Abstract] [Full Text] [Related]
8. Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?
Mennitto A; Grassi P; Verzoni E; Ratta R; Procopio G
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):250-251. PubMed ID: 28070961
[No Abstract] [Full Text] [Related]
9. 18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
Bertagna F; Fisogni S; Tardanico R; Simeone C; Cunico SC; Giubbini R
Clin Nucl Med; 2012 Oct; 37(10):986-8. PubMed ID: 22955073
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography imaging of renal vein and inferior vena cava tumor thrombus from renal cell carcinoma.
Nguyen BD
Clin Nucl Med; 2005 Feb; 30(2):107-9. PubMed ID: 15647678
[No Abstract] [Full Text] [Related]
11. Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.
Harrison MR; George DJ
Clin Cancer Res; 2011 Sep; 17(18):5841-3. PubMed ID: 21926167
[TBL] [Abstract][Full Text] [Related]
12. F-18 FDG PET findings in a port site recurrence after laparoscopic radical nephrectomy in a patient with renal cell carcinoma.
Malhotra G; Nair N; Abhyankar A; Awasare S; Moghe SH
Clin Nucl Med; 2008 Feb; 33(2):146-7. PubMed ID: 18209545
[No Abstract] [Full Text] [Related]
13. Metastatic Renal Cell Cancer Treated With Antiangiogenic Therapy Monitoring by 18F-FDG PET/CT.
García Garzon JR; Bassa P; Llinares E; Soler M; Moragas M; Riera E
Clin Nucl Med; 2015 Nov; 40(11):910-1. PubMed ID: 26252325
[TBL] [Abstract][Full Text] [Related]
14. Primary synovial sarcoma of the kidney: use of PET/CT in diagnosis and follow-up.
Erturhan S; Seçkiner I; Zincirkeser S; Erbagci A; Celik M; Yagci F; Karakok M
Ann Nucl Med; 2008 Apr; 22(3):225-9. PubMed ID: 18498039
[TBL] [Abstract][Full Text] [Related]
15. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan.
Aurangabadkar H; Ali Z
Clin Nucl Med; 2013 Dec; 38(12):e471-3. PubMed ID: 23603603
[TBL] [Abstract][Full Text] [Related]
16. Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography.
Ishikawa I; Morita K; Hayama S; Nakazawa T; Araki I; Higashi K; Miyazawa K; Suzuki K; Nojima T
Clin Exp Nephrol; 2011 Feb; 15(1):136-40. PubMed ID: 20824295
[TBL] [Abstract][Full Text] [Related]
17. CT with anatomic delineation identifying renal cell carcinoma with normal metabolic activity on F-18 FDG PET imaging.
Cherng SC; Chang CY; Fan YM; Chen CY; Chiu CS; Cheng CY
Clin Nucl Med; 2006 Aug; 31(8):490-1. PubMed ID: 16855441
[No Abstract] [Full Text] [Related]
18. PET/CT with (124)I-cG250: great potential and some open questions.
Khandani AH; Rathmell WK; Wallen EM; Ivanovic M
AJR Am J Roentgenol; 2014 Aug; 203(2):261-2. PubMed ID: 25055257
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer.
Chessin DB; Kiran RP; Akhurst T; Guillem JG
J Am Coll Surg; 2005 Dec; 201(6):948-56. PubMed ID: 16310700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
